Bank Of New York Mellon Corp Cassava Sciences Inc Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$23.46 - $36.44 $2.99 Million - $4.64 Million	127,285 New	127,285 $3.07 Billion
Q4 2022 Feb 14, 2023	BUY	$27.82 - $44.16 $3.61 Million - $5.73 Million	129,650 New	129,650 $3.83 Million
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $202,622 - $633,552	12,408 Added 10.66%	128,794 $5.39 Million
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $113,772 - $254,171	-6,607 Reduced 5.37%	116,386 $3.27 Million
Q1 2022 May 11, 2022	BUY	$32.6 - $53.05 $23,211 - $37,771	712 Added 0.58%	122,993 $4.57 Million
Q4 2021 Feb 11, 2022	SELL	$36.77 - $90.91 $46,697 - $115,455	-1,270 Reduced 1.03%	122,281 $5.34 Million
Q3 2021 Nov 12, 2021	SELL	$41.79 - $135.3 $326,296 - $1.06 Million	-7,808 Reduced 5.94%	123,551 $7.67 Million
Q2 2021 Aug 11, 2021	SELL	$32.15 - $89.72 $489,515 - $1.37 Million	-15,226 Reduced 10.39%	131,359 $11.2 Million
Q1 2021 May 13, 2021	SELL	$7.09 - $87.95 $149,003 - $1.85 Million	-21,016 Reduced 12.54%	146,585 $6.59 Million
Q4 2020 Feb 09, 2021	BUY	$6.79 - $12.25 $219,405 - $395,834	32,313 Added 23.88%	167,601 $1.14 Million
Q2 2020 Aug 12, 2020	BUY	$2.04 - $9.64 $117,469 - $555,100	57,583 Added 74.1%	135,288 $416,000
Q1 2020 May 06, 2020	BUY	$3.26 - $9.65 $181,256 - $536,540	55,600 Added 251.53%	77,705 $319,000
Q1 2019 May 14, 2019	BUY	$0.92 - $1.29 $20,336 - $28,515	22,105 New	22,105 $29,000

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.